ORIGIN MATERIALS, INC. (ORGN)
Origin Announces Plan to Sell Technology Followed by Orderly Wind Down of Operations
TAITRON COMPONENTS, INC. (TAIT)
Taitron Announces Quarterly Cash Dividend
CARDLYTICS, INC. (CDLX)
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
INSPIREMD, INC. (NSPR)
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
EXTREME NETWORKS INC (EXTR)
Extreme Networks Announces Investor Conferences for May and June 2026
TAYSHA GENE THERAPIES, INC. (TSHA)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEUROCRINE BIOSCIENCES INC (NBIX)
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients with Classic Congenital Adrenal Hyperplasia
FATE THERAPEUTICS INC (FATE)
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
INSPIREMD, INC. (NSPR)
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
DAVE & BUSTER''S ENTERTAINMENT, INC. (PLAY)
Dave & Buster’s Announces Board of Directors Transition
TITAN AMERICA SA (TTAM)
Titan America Closes Acquisition of Keystone Cement Company
SOLID BIOSCIENCES INC. (SLDB)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TRANSACT TECHNOLOGIES INC (TACT)
TransAct Technologies to Report First Quarter 2026 Results On May 12, 2026, Host Conference Call and Webcast
MYOMO, INC. (MYO)
Myomo to Report First Quarter 2026 Financial Results on May 7
REINSURANCE GROUP OF AMERICA INC (RGA)
Reinsurance Group of America Announces Redemption of All of Its Outstanding 5.75% Fixed-to-Floating Rate Subordinated Debentures Due 2056